Tissutal immune profile and pathological complete response in triple negative breast cancer

被引：0
|
作者：
Botticelli, Andrea [1 ]
Cerbelli, Bruna [1 ]
Scagnoli, Simone [1 ]
Amabile, Maria Ida [1 ]
De Luca, Alessandro [1 ]
Fortunato, Lucio [2 ]
Costarelli, Leopoldo [2 ]
Nuti, Marianna [1 ]
D'Amati, Giulia [1 ]
Marchetti, Paolo [1 ]
机构：
[1] Sapienza Univ Rome, Rome, Italy
[2] San Giovanni Addolorata Hosp, Rome, Italy
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2019年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P114
引用
收藏
页数：2
相关论文
共 50 条
  • [31] A microRNA signature associated with pathological complete response to novel neoadjuvant therapy regimen in triple-negative breast cancer
    Garcia-Vazquez, Raul
    Ruiz-Garcia, Erika
    Meneses Garcia, Abelardo
    Astudillo-de la Vega, Horacio
    Lara-Medina, Fernando
    Alvarado-Miranda, Alberto
    Maldonado-Martinez, Hector
    Gonzalez-Barrios, Juan A.
    Campos-Parra, Alma D.
    Rodriguez Cuevas, Sergio
    Marchat, Laurence A.
    Lopez-Camarillo, Cesar
    TUMOR BIOLOGY, 2017, 39 (06)
  • [32] Predictive biomarkers for pathological complete response in early-stage triple negative breast cancer following neoadjuvant chemotherapy
    Polho, Gabriel Berlingieri
    Testa, Laura
    Barroso-Sousa, Romualdo
    Bonadio, Renata Colombo
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [33] Predictive value of tumour infiltrating lymphocytes to pathological complete response in neoadjuvant treated triple-negative breast cancer
    Babbar, P. N.
    ANNALS OF ONCOLOGY, 2020, 31 : S1239 - S1239
  • [34] A Predictor of Pathological Complete Response to Neoadjuvant Chemotherapy Stratifies Triple Negative Breast Cancer Patients with High Risk of Recurrence
    Fournier, Marcia, V
    Goodwin, Edward C.
    Chen, Joan
    Obenauer, John C.
    Tannenbaum, Susan H.
    Brufsky, Adam M.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [35] Predictive markers for pathological complete response after neo-adjuvant chemotherapy in triple-negative breast cancer
    Van Bockstal, Mieke R.
    Noel, Fanchon
    Guiot, Yves
    Duhoux, Francois P.
    Mazzeo, Filomena
    Van Marcke, Cedric
    Fellah, Latifa
    Ledoux, Benjamin
    Berliere, Martine
    Galant, Christine
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2020, 49
  • [36] Transcriptomic expression of immunological markers associated with pathological complete response in patients with triple negative breast cancer in NACATRINE trial
    de Freitas, A. J.
    Nunes, C. R.
    Causin, R. L.
    de Oliveira, M. A.
    Souza, C. P.
    Marques, M. M. C.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1324 - S1324
  • [37] Tumor immune microenvironment and genomic evolution in a patient with metastatic triple negative breast cancer and a complete response to atezolizumab
    Molinero, Luciana
    Li, Yijin
    Chang, Ching-Wei
    Maund, Sophia
    Berg, Maureen
    Harrison, Jeanne
    Fasso, Marcella
    O'Hear, Carol
    Hegde, Priti
    Emens, Leisha A.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01):
  • [38] Is complete pathological response truly a complete response in breast cancer?
    Rehman, Bushra
    Rehman, Sara
    Mohtasham, Sameen
    Zahid, Toqeer
    Sarwar, Albash
    Parvaiz, Muhammad Asad
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2023, 73 (02) : 280 - 283
  • [39] Predictive factors of pathological complete response to neoadjuvant therapy in triple-negative breast carcinoma
    Costa, J.
    Coimbra, N.
    Lopes, P.
    Antunes, L.
    Souto Moura, M.
    Leal, C.
    VIRCHOWS ARCHIV, 2020, 477 : S44 - S44
  • [40] The prognostic value of the neoadjuvant response index in triple-negative breast cancer: validation and comparison with pathological complete response as outcome measure
    M. Jebbink
    E. van Werkhoven
    I. A. M. Mandjes
    J. Wesseling
    E. H. Lips
    M.-J. T. D. F. Vrancken Peeters
    C. E. Loo
    G. S. Sonke
    S. C. Linn
    C. Falo Zamora
    S. Rodenhuis
    Breast Cancer Research and Treatment, 2015, 153 : 145 - 152
12345